FDA Inspection
GH Genhelix S.A.GH Genhelix S.A. – FDA Inspection, Oct 26, 2022
Record Details
This FDA Inspection record concerns GH Genhelix S.A., with an inspection on October 26, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- GH Genhelix S.A.
- Inspection Date
- October 26, 2022
- Product Type
- Drugs
View Company Profile
ID · f8996d6d-2d43-4287-9114-7e825c8b9cf1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276827
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of GH Genhelix S.A.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GH Genhelix S.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.